rs142974032
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_017433.5(MYO3A):c.2918G>A(p.Arg973Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000496 in 1,613,938 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_017433.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152094Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251236Hom.: 1 AF XY: 0.000147 AC XY: 20AN XY: 135786
GnomAD4 exome AF: 0.0000458 AC: 67AN: 1461844Hom.: 1 Cov.: 33 AF XY: 0.0000674 AC XY: 49AN XY: 727224
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152094Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74306
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Arg973Gln variant in MYO3A has not been previously reported in individuals with hearing loss, but has been identified in 12/16510 of South Asian chromosom es and 5/10406 of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs142974032). Although this variant has b een seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation analysis sug gest that the p.Arg973Gln variant may impact the protein, though this informatio n is not predictive enough to determine pathogenicity. In summary, the clinical significance of the p.Arg973Gln variant is uncertain. -
Inborn genetic diseases Uncertain:1
The c.2918G>A (p.R973Q) alteration is located in exon 26 (coding exon 24) of the MYO3A gene. This alteration results from a G to A substitution at nucleotide position 2918, causing the arginine (R) at amino acid position 973 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 973 of the MYO3A protein (p.Arg973Gln). This variant is present in population databases (rs142974032, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with MYO3A-related conditions. ClinVar contains an entry for this variant (Variation ID: 228982). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MYO3A protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at